NASA is sending a suite of experiments dedicated to understanding human and plant health alongside investigations into drug-resistant organisms to the International Space Station via SpaceX's CRS-35 mission. The launch is scheduled to originate from Cape Canaveral Space Force Station in Florida, marking a significant step forward in space-based research efforts. These experiments are designed to directly support astronaut well-being throughout extended stays in orbit, addressing critical needs for long-duration spaceflight. Specifically, the research will examine how microgravity impacts biological systems, providing valuable data for future exploration endeavors. Ultimately, this initiative aims to translate findings into tangible benefits for life on Earth through advancements in medicine and biology.
Continue reading at www.nasa.gov
This PlaneNews briefing summarizes reporting originally published by www.nasa.gov.
Read the original article →